Irena Molnar is a Serbian youth activist, working on promoting harm reduction and safer nightlife programs in South-Eastern Europe. Please read our interview and learn about her insights on regional developments!

Read our annual report and learn about the work what we do: filming, networking, training and advocacy!

How does the war on drugs affect women? Is it really so different from how it affects men? Our knowledge was very limited before we interviewed the participants of an international workshop in Budapest. Please watch our video report and read our article!

After the office was raided and computers were seized, the members of the staff and the Steering Committee announced their resignation from EHRN. Is this the end of the network? No, it is only the end of EHRN as an organisation but the network is alive and well. Another NGO has been registered to provide a new organisational framework. This is the story from the former co-chair’s perspective!

The New Zealand Drug Foundation has been in the forefront of drug policy debates in New Zealand for more than 25 years. We interviewed its director, Ross Bell, about the chances of reforming drug laws in his country.

The legal regulation of drugs is more effective and just than prohibition. But does it really fix most problems? Not without social justice. (This article is available in Spanish, Portuguese and Italian)

Our movie gives you an overview of the crisis of harm reduction programs in Bosnia-Herzegovina, where harm reducers don’t receive support from the government but they keep doing their work and saving lives.

The Catalonian parliament has recently adopted a new law to regulate the cannabis market. We interviewed Òscar Parés, the deputy director of the International Center for Ethnobotanical Education, Research & Service to learn more about the cannabis reconquista movement in Spain.

Whilst experiences with psychedelic drugs share common elements, psychedelics are, chemically speaking, a broad class of drugs. In this Dose of Science, we take a look at a study that has measured the pharmacological properties of 35 psychedelic substances, shining some light on the similarities and differences between their biochemical profiles.

Although it was without much fanfare that the European Commission, in July 2017, published the new Action Plan on Drugs (2017-2020), the drug policy community should celebrate it as a great achievement both for its progressive content and for the meaningful involvement of civil society in its preparation. [There is a Polish, Estonian, Hungarian and Serbian translation of this article!]